Examkin

Question

Difficulty: MediumPreventive Care and Immunizations

A 2-month-old girl is brought to the pediatrician by her parents for her first routine well-child visit. She was born at 39 weeks gestation via an uncomplicated spontaneous vaginal delivery. Her mother has a history of severe Crohn disease, which has been well controlled with infliximab therapy. The mother received scheduled infliximab infusions throughout her pregnancy, with the final dose administered 3 weeks prior to delivery. The infant is exclusively breastfed and is gaining weight appropriately. Physical examination reveals an alert, active infant with normal vital signs and no abnormalities. In addition to the second dose of the hepatitis B vaccine, the infant is due for her first doses of the diphtheria, tetanus, and acellular pertussis (DTaP), Haemophilus influenzae type b (Hib), inactivated polio (IPV), pneumococcal conjugate (PCV15), and rotavirus vaccines. Which of the following is the most appropriate recommendation regarding this patient's immunizations today?

  1. A
    Administer all scheduled vaccines, including rotavirus
  2. Administer all scheduled inactivated vaccines; withhold the rotavirus vaccine entirelyAnswer
  3. C
    Withhold all vaccines today and reschedule them when the infant is 6 months of age
  4. D
    Administer all scheduled inactivated vaccines today; delay the rotavirus vaccine until 6 months of age
  5. E
    Advise the mother to suspend breastfeeding for 48 hours, then administer all scheduled vaccines

Answer

Administer all scheduled inactivated vaccines; withhold the rotavirus vaccine entirely.
Infliximab is an IgG1 monoclonal antibody targeting TNF-alpha. Like other maternal IgG antibodies, it actively crosses the placenta, primarily during the third trimester. Infants born to mothers receiving infliximab can have detectable, immunosuppressive serum levels of the drug for up to 6 months after birth. Because of the risk of severe, disseminated infection in an immunocompromised host, all live-attenuated vaccines (including the oral rotavirus vaccine) are contraindicated in these infants during their first 6 months of life. Therefore, the rotavirus vaccine must be withheld. However, all inactivated, toxoid, and recombinant vaccines (such as DTaP, Hib, IPV, PCV15, and HepB) are completely safe, carry no risk of vaccine-strain infection, and should be administered according to the routine schedule to ensure timely protection.

Step-by-Step Solution

1
Identify the maternal medication and its mechanism of action.
The mother is taking infliximab, an IgG1 monoclonal antibody against TNF-alpha.
To understand the potential immunological risk to the fetus and infant.
2
Determine the extent of placental transfer of the medication.
Maternal IgG antibodies actively cross the placenta, especially during the third trimester, leading to significant serum levels of infliximab in the infant that can persist for up to 6 months.
To assess if the infant is systematically exposed and potentially immunosuppressed.
3
Identify the nature of the scheduled vaccines.
Rotavirus is a live-attenuated oral vaccine. DTaP, Hib, IPV, PCV15, and HepB are inactivated, toxoid, or recombinant vaccines.
Different vaccine types have fundamentally different safety profiles in immunocompromised hosts.
4
Apply immunization guidelines for infants exposed to maternal biologics in utero.
Live vaccines (rotavirus) are contraindicated for the first 6 months of life. Inactivated vaccines should be given on the normal schedule. Because the rotavirus vaccine series cannot be initiated after 14 weeks and 6 days, this infant will age out of eligibility and must skip the rotavirus series entirely.
To provide safe and effective preventive care while adhering to established contraindications.

Key Concept

Live-attenuated vaccines, such as rotavirus, are contraindicated for the first 6 months of life in infants exposed in utero to maternal biologic response modifiers (e.g., TNF-alpha inhibitors) due to the risk of disseminated vaccine-strain infection.
Estimated Time:1m 15s
Rate this question

Topics

Preventive Care and Immunizations

More questions from this topic